Search Results - "Munje, Chinmay"
-
1
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
Published in Leukemia (01-06-2020)“…The introduction of BCR-ABL tyrosine kinase inhibitors has revolutionized the treatment of chronic myeloid leukemia (CML). A major clinical aim remains the…”
Get full text
Journal Article -
2
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Published in Leukemia (01-02-2020)“…Inappropriate localization of proteins can interfere with normal cellular function and drive tumor development. To understand how this contributes to the…”
Get full text
Journal Article -
3
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
Published in Leukemia (01-07-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
4
Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling
Published in Blood (07-11-2013)“…Excessive production of reactive oxygen species (ROS) is frequently observed in cancer and is known to strongly influence hematopoietic cell function. Here we…”
Get full text
Journal Article -
5
Gene Expression Profiling of CD93-Selected CP-CML Stem Cells Confirms Their Quiescent Character and Biomarker Potential
Published in Blood (02-12-2016)“…The introduction of BCR-ABL tyrosine kinase inhibitors has revolutionized the treatment of chronic myeloid leukemia (CML). A major clinical aim remains the…”
Get full text
Journal Article -
6
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
Published in Cancers (27-09-2022)“…RNA splicing factors are frequently altered in cancer and can act as both oncoproteins and tumour suppressors. They have been found mutated or deregulated,…”
Get full text
Journal Article -
7
The Complexity of Identifying Cancer Stem Cell Biomarkers
Published in Cancer investigation (01-07-2013)“…The efficacy of glioma therapy can be considerably improved if it eliminates cancer stem cells (CSCs); however, to achieve this, CSCs markers are required…”
Get full text
Journal Article -
8
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy
Published in Cancers (26-10-2022)“…Tyrosine kinase inhibitors (TKI) have revolutionised the treatment of CML. However, TKI do not eliminate the leukaemia stem cells (LSC), which can re-initiate…”
Get full text
Journal Article -
9
A Subpopulation of Blasts with Attenuated p38MAPK Response Is Seen in Virtually All AML Patients and AML Cell Lines and Is Defined By Cells with Augmented Lipid-Associated Anti-Oxidant Defense
Published in Blood (06-12-2014)“…The serine/ threonine kinase, p38MAPK is activated by phosphorylation in response to a variety of cellular stresses including oxidative stress. Prolonged…”
Get full text
Journal Article -
10
Integrated Nuclear Proteomics and Transcriptomics Identifies New High Frequency Dysregulated Transcription Factors in AML
Published in Blood (06-12-2014)“…Acute myeloid leukemia (AML) is characterized by developmental arrest which is thought to arise from transcriptional dysregulation of myeloid development…”
Get full text
Journal Article -
11
A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α
Published in Cancers (08-12-2011)“…Hsp90α's vital role in tumour survival and progression, together with its highly inducible expression profile in gliomas and its absence in normal tissue and…”
Get full text
Journal Article -
12
Can hsp90α-Targeted siRNA Combined With TMZ Be a Future Therapy for Glioma?
Published in Cancer investigation (01-06-2010)“…ABSTRACT Hsp90α's vital role in cell cycle progression and apoptosis together with its presence in gliomas and absence in normal tissue, make it a credible…”
Get full text
Journal Article -
13
Cord Blood-Derived Quiescent CD34 super(+) Cells Are More Transcriptionally Matched to AML Blasts Than Cytokine-Induced Normal Human Hematopoietic CD34 super(+) Cells
Published in Gene expression (01-01-2015)“…Acute myeloid leukemia (AML) is characterized by developmental arrest, which is thought to arise from transcriptional dysregulation of myeloid development…”
Get full text
Journal Article -
14
A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a
Published in Cancers (08-12-2011)“…Hsp90a's vital role in tumour survival and progression, together with its highly inducible expression profile in gliomas and its absence in normal tissue and…”
Get full text
Journal Article -
15
Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to AML Blasts Than Cytokine-Induced Normal Human Hematopoietic CD34+ Cells
Published in Gene expression (01-01-2015)“…Acute myeloid leukemia (AML) is characterized by developmental arrest, which is thought to arise from transcriptional dysregulation of myeloid development…”
Get full text
Journal Article -
16
Hsp90 as a molecular target
Published 01-01-2011“…Heat shock protein 90 (Hsp90), a highly conserved molecular chaperone, has been proposed to play a vital role in tumorigenesis. Hsp90 has two isoforms, of…”
Get full text
Dissertation -
17
Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?
Published in Cancer investigation (01-07-2010)“…Hsp90alpha's vital role in cell cycle progression and apoptosis together with its presence in gliomas and absence in normal tissue, make it a credible target…”
Get full text
Journal Article